Moreover, compared with the CRC group, mice in the ZS40-L and BLA treatment groups and the SD control group had effectively reduced levels of IL-1β, IL-8, TNF-α, MIP-1β, and VCAM-1; SD showed a better effect in reducing the levels of inflammatory factors (p < 0.05). The gene discussed is IL1B; the disease is colorectal carcinoma.